Related Experiment Video
Updated: May 21, 2026
10:12
Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Study of hepatitis C virus entry in genetically humanized mice
Marcus Dorner1, Charles M Rice, Alexander Ploss
1Center for the Study of Hepatitis C, Laboratory for Virology and Infectious Disease, The Rockefeller University, New York, NY 10065, USA.
Methods (San Diego, Calif.)
|June 13, 2012
Summary
A new genetically humanized mouse model allows for studying hepatitis C virus (HCV) infection in mice. This model overcomes limitations of previous methods, aiding HCV research and drug development.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Chronic hepatitis C virus (HCV) infection affects 2% of the global population, potentially leading to liver disease and cancer.
- Current HCV therapies have limited effectiveness, and no vaccine is available.
- Studying HCV in its natural liver environment is challenging due to narrow species tropism.
Purpose of the Study:
- To develop a genetically humanized mouse model for studying hepatitis C virus (HCV) infection.
- To overcome the limitations of existing mouse models for HCV research.
- To provide a protocol for generating and utilizing this novel model for preclinical drug and vaccine testing.
Main Methods:
- Genetically humanized mouse model construction by enabling expression of human CD81 and human OCLN.
- Detailed protocol for animal generation.
- Application of the model for studying HCV biology and preclinical testing.
Main Results:
- Successful generation of a genetically humanized mouse model susceptible to HCV infection.
- Demonstration of the model's utility in studying HCV infection dynamics.
- Validation of the model for preclinical evaluation of therapeutic candidates.
Conclusions:
- The genetically humanized mouse model offers a valuable tool for advancing hepatitis C virus (HCV) research.
- This model addresses key limitations of previous experimental systems, enabling better understanding of HCV infection.
- It facilitates preclinical testing of drugs and vaccines, potentially accelerating the development of new treatments.
